CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Penicillin G Benzathine Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2023-04-26. Latest FDA row update: 2026-09-21.
FDA lists 4 package records, with companies: LABORATRIOS ATRAL, S.A., Laboratorios Atral, Pfizer Inc., Pfizer Laboratories Div Pfizer Inc. Package NDCs: 60793-700-10, 60793-701-10, 60793-702-10, 84383-110-01.
FDA shortage reason: Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Laboratorios Atral | 84383-110-01 | Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01) | Available | 2026-09-15 |
| Pfizer Inc. | 60793-701-10 | Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10) | Limited Availability | 2026-09-21 |
| Pfizer Inc. | 60793-702-10 | Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10) | Limited Availability | 2026-09-21 |
| Pfizer Inc. | 60793-700-10 | Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10) | Unavailable | 2026-09-21 |
Source facts
Grouped generic ingredient: Penicillin G Benzathine Injection · 4 package records
Therapeutic categories: Anti-Infective
Dosage forms: Injection
Routes: INTRAMUSCULAR
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.